| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |